FREmedica Technologies has commercially launched its NIKKI Lyme Wellness Program through Ergopathics, which serves over 7,000 practitioner clinics in the US. This partnership allows clinics using Ergopathics' frequency-based assessment technology to offer NIKKI as a complementary wellness solution, supporting healing with frequency-based programs. The launch marks a key milestone for FREmedica, with potential future expansions into wellness programs for sleep, stress, energy, and recovery. Clinics independently decide whether to recommend NIKKI, with no sales guarantees involved in the agreement.
Crescent Biopharma announced its second quarter 2026 financial results, highlighting progress in clinical trials for its cancer therapies, including CR-001, a PD-1 x VEGF bispecific antibody, and ADC candidates CR-002 and CR-003. The company is enrol...
Ferrari reported Q2 2026 net revenues of €1.94 billion, up 8% year-on-year, driven by a richer product mix and increased personalization sales. Operating profit rose 10% to €605 million with a margin of 31.2%, while net profit grew 9% to €463 million...
Republic Services reported $973 million in sustainability investments in 2025, including launching nine renewable natural gas projects and expanding its electric truck fleet to over 180 vehicles. These efforts support the company's 2030 goals for saf...
Co-Diagnostics, a molecular diagnostics company, announced it will release its second quarter 2026 financial results on August 13, 2026, after market close. The company will hold a conference call and webcast at 4:30 p.m. ET the same day to discuss t...
Oracle and Google Cloud have expanded their partnership to integrate Google's Gemini AI models into Oracle's Fusion Cloud Applications and NetSuite. This integration allows customers to automate processes, accelerate decisions, and enhance AI-driven ...
